Tirzepatide Injection or Tablet? What a Week Looks Like With Each Format

When a provider prescribes tirzepatide, one practical question follows: which format? Tirzepatide is a prescription medication that acts on two gut-hormone pathways, GIP and GLP-1. Through Nu Image it may be prescribed as a weekly injection or as a daily rapid-dissolve tablet. The two involve quite different routines. This guide walks through a typical week with each so you can picture which one you would keep up with. It is educational and does not replace the instructions for your own prescription.

First, what both formats share

• Both are compounded medications. They are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
• Both require a prescription after review by a licensed provider.
• Both start at a low dose that is adjusted gradually.
• Both carry the same precautions, including those about thyroid cancer history, pregnancy, and birth control pills.
• Both work alongside nutrition, activity, and follow-up.

A week with the injection

Dose day. You pick one day of the week and keep to it. On that day you wash your hands, check the vial, draw up the prescribed amount, and inject just under the skin of the abdomen, thigh, or upper arm. The whole process takes a few minutes.

The other six days. There is nothing to take. The vial stays stored as your label directs, which often means in the refrigerator.

What it asks of you.

• Comfort with a small needle
• Care in measuring the dose, in both milligrams and syringe units
• A sharps container for used needles
• Suitable storage, including when you travel
• Remembering one fixed day each week

A week with the tablet

Every day. You take one tablet at about the same time each day, placing it in the mouth to dissolve as your prescription directs. There is no measuring and no needle.

What it asks of you.

• A reliable daily habit, seven days a week
• Following the instructions on timing and on eating or drinking around the dose
• Keeping the tablets dry and stored as directed

An important point about the tablet

The published research on tirzepatide has been carried out with injections. No tablet form of tirzepatide is FDA-approved, and compounded rapid-dissolve tablets have not been evaluated by the FDA. Ask your provider what is known about the tablet format and why it is or is not being recommended for you.

Side by side

Questions to ask yourself

1. Am I more likely to remember one day a week or every day?
2. How do I feel about giving myself an injection?
3. Do I travel often, and can I keep a vial at the right temperature?
4. Am I confident measuring a dose accurately?
5. What does each format cost me per month?

If the format is not working

Tell your provider. Changing format, like changing dose, is a decision for the provider, who will give you instructions for the switch. Do not move between formats or combine them on your own.

Safety reminders for either format

• Do not take more than prescribed or increase the dose yourself
• Tirzepatide can make birth control pills less reliable around the start and each dose increase
• It is not used during pregnancy
• Tell your surgical team about it before any procedure with anesthesia
• Seek urgent care for severe abdominal pain that does not go away or signs of an allergic reaction

Getting an evaluation

Nu Image offers online evaluations with licensed providers, who review your history, decide whether a prescription is appropriate, and discuss which format suits you.

This content is for educational purposes only and is not medical advice, diagnosis, or treatment. Compounded medications are prepared by state-licensed compounding pharmacies and are not reviewed or approved by the FDA for safety, efficacy, or quality. Prescription products require an online consultation with a licensed healthcare provider, who will determine whether a prescription is appropriate.